Arcus Biosciences (RCUS) Consolidated Net Income: 2017-2025
Historic Consolidated Net Income for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to -$135.0 million.
- Arcus Biosciences' Consolidated Net Income fell 46.74% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$433.0 million, marking a year-over-year decrease of 60.37%. This contributed to the annual value of -$283.0 million for FY2024, which is 7.82% up from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Consolidated Net Income is -$135.0 million, which was down 20.54% from -$112.0 million recorded in Q1 2025.
- Arcus Biosciences' 5-year Consolidated Net Income high stood at $279.5 million for Q4 2021, and its period low was -$135.0 million during Q3 2025.
- In the last 3 years, Arcus Biosciences' Consolidated Net Income had a median value of -$86.5 million in 2023 and averaged -$83.7 million.
- Over the last 5 years, Arcus Biosciences' Consolidated Net Income had its largest YoY gain of 637.62% in 2021, and its largest YoY loss of 4,379.64% in 2021.
- Arcus Biosciences' Consolidated Net Income (Quarterly) stood at $279.5 million in 2021, then plummeted by 123.97% to -$67.0 million in 2022, then decreased by 20.90% to -$81.0 million in 2023, then fell by 16.05% to -$94.0 million in 2024, then tumbled by 46.74% to -$135.0 million in 2025.
- Its Consolidated Net Income was -$135.0 million in Q3 2025, compared to -$112.0 million in Q1 2025 and -$94.0 million in Q4 2024.